ArticleCureus2026
Barriers to Maternal Presence at the Bedside of Infants With Neonatal Opioid Withdrawal Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Neonatal opioid withdrawal syndrome (NOWS) occurs in infants exposed to opioids during pregnancy. Caregiver presence is an important component of family-centered NOWS care. This study compared documented caregiver bedside presence and clinical outcomes before and after implementation of the Eat, Sleep, Console (ESC) approach and explored barriers to bedside presence reported by mothers in the ESC cohort. Methods We compared a retrospective non-ESC cohort of infants with NOWS admitted to an academic general pediatrics floor from August through December 2021 with a prospective ESC cohort admitted from May through August 2022. Clinical variables included length of stay (LOS), morphine receipt and duration, adjuvant pharmacologic therapy, and documented caregiver bedside presence. Mothers in the ESC cohort were invited to provide exploratory feedback regarding barriers to bedside presence. Results Fifty-four infants were included (41 non-ESC; 13 ESC). No statistically significant differences were observed in LOS, morphine receipt, morphine duration, adjuvant pharmacologic therapy, or documented caregiver bedside presence. Four of 13 mothers in the ESC cohort completed follow-up; two described concerns related to communication, shared decision-making, and perceived stigma. Conclusion Clinical outcomes and documented caregiver bedside presence did not differ significantly between cohorts. Maternal feedback was limited and should be considered exploratory, but it identified provider-family communication and support as potential areas for further study. Larger prospective studies with more precise measurement of caregiver presence and systematic assessment of family experiences are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.